MLchartDataset catalogue

allogeneic large multivalent immunogen breast cancer vaccine

Term · Oncology and biomedicine · MLC-T-ONC-009915

A cancer vaccine, containing human-specific large multivalent immunogens (LMIs) isolated from the membrane fraction of cells from a breast cancer cell line, with potential immunostimulatory and antineoplastic activities. Upon administration, allogeneic large multivalent immunogen breast cancer vaccine may stimulate a cytotoxic T lymphocyte (CTL) immune response against tumor cells that express the breast cancer cell-specific LMIs.

Table 1. Record
IdentifierMLC-T-ONC-009915
FieldOncology and biomedicine
Synonymsallogeneic LMI breast cancer vaccine
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-009915",
  "term": "allogeneic large multivalent immunogen breast cancer vaccine",
  "field": "Oncology and biomedicine",
  "definition": "A cancer vaccine, containing human-specific large multivalent immunogens (LMIs) isolated from the membrane fraction of cells from a breast cancer cell line, with potential immunostimulatory and antineoplastic activities. Upon administration, allogeneic large multivalent immunogen breast cancer vaccine may stimulate a cytotoxic T lymphocyte (CTL) immune response against tumor cells that express the breast cancer cell-specific LMIs.",
  "synonyms": [
    "allogeneic LMI breast cancer vaccine"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/allogeneic-large-multivalent-immunogen-breast-cancer-vaccine/"
}

Record 801 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.